DealShot: Lilly Asia Ventures Leads $14.5M Pre-B Round In Chinese Biotech Company EdiGene

Follow Us:

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money each workday.

CompanyRoundLead InvestorParticipantsSectorHeadquarters
EdiGenePre-BLilly Asia VenturesIDG Capital, HG Capital, WI Harper GroupHealthcareBeijing
OneSpaceSeries BCICC Jiatai Equity FundsFinTrek Capital, China Merchants Venture Capital, Qianhai Wande Fund, Qianhai Wutong M&A FundTransportation & SpaceBeijing
Changchong Technology/FreechargeSeries A+Li Yifei, Ji Xuefeng, Xu Renbin, Wang YueSmart HardwareBeijing
EartharborPre-ADFJ DragonFund ChinaConsumer UpgradeBeijing
ZhenzhizhuojianAngel RoundundisclosedMedia & EntertainmentBeijing
ZhangguigonglueSeries A+Qingsong FundChina Growth CapitalMedia & EntertainmentBeijing
Shangyi Information TechnologySeries BIDG CapitalHealthcareChengdu
TONOTSeries ABertelsmann Asia InvestmentsSmart HardwareShenzhen
Zen VideoSeries A+Toutoushidao CapitalAI & RoboticsHangzhou
XmeBankSeries AQiuling Capital, Baika VenturesFintechBeijing
AnngicSeries AFortune Venture CapitalSmart HardwareShenzhen
Mydream+Series CHillhouse CapitalJoy Capital, Ocean Link, K2VC, M31 Capital Real EstateBeijing
Bus365.comSeries BSBCVCAlibaba Group, China Development Bank International Investment LimitedTransportation & SpaceBeijing
Ackerman BoitechSeries AFortune Venture Capital, Insight CapitalHealthcareShanghai

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *